Skip to content
Cansu's ADHD Diary
All articles

Does Omega-3 Help ADHD? What the Cochrane Review Found

The most talked-about product on the supplement shelf. The small effect older meta-analyses found, the Cochrane review's result, and what to consider when deciding.

Cansu6 min readMedium

Türkçe okuShare on Reddit

In the first months after the diagnosis I spent quite a lot of time at the pharmacy. Most of it at the omega-3 shelf. The box said "focus," and at that time I was very hungry for that word.

I bought it, used it, felt nothing, and explained this to myself as "I bought the wrong brand." Then I looked at the numbers.

The answer to this question changed over time, and the direction of the change matters.

First, the old picture

The meta-analysis by Bloch and Qawasmi (2011) pooled ten randomized controlled trials on the subject. A total of 699 children. The result was a standardized mean difference of 0.31 in favor of omega-3.

Let us unpack what this number means. Effect sizes are roughly interpreted like this: 0.2 is small, 0.5 is medium, 0.8 is large. So 0.31 lies between small and medium, an effect close to small.

The meta-analysis by Chang and colleagues (2018), which pooled seven randomized trials, reported a similar result: in 534 children and adolescents, an improvement of 0.38 in symptom scores.

For comparison: in the network meta-analysis by Cortese and colleagues (2018), the effects of ADHD medications on core symptoms are measured as markedly higher.

Then the picture changed

The Cochrane review published in 2023 brought together 37 studies examining polyunsaturated fatty acids, with more than 2,300 participants. That is about three times as many studies as in the earlier reviews.

The result: it is reported, with high-certainty evidence, that omega-3 supplementation did not improve ADHD symptoms compared with placebo, either overall or in the inattention and hyperactivity/impulsivity subdomains (Gillies et al., 2023).

So when the number of studies tripled, the small effect disappeared.

An effect that shrinks as evidence accumulates is often not a real effect.

This is a good example of how the field works: promising findings that begin with a small number of small studies can fade as the number of studies grows. The meta-analysis by Sonuga-Barke and colleagues (2013) points the same way: for non-drug approaches, the effects shrink markedly when the assessment is blinded. The expectations of families and teachers affect the results.

The matter of dose and EPA

The old meta-analysis contained an interesting detail: dose dependence. Studies that included 500-750 mg of EPA a day had given more effective results (Bloch & Qawasmi, 2011).

This information is still in circulation and often appears on pages that sell supplements. But it now has to be read within a different frame: if no overall effect can be shown, the practical meaning of the dose detail weakens too.

How much to take and for how long is something for a doctor to say; there is no dose recommendation here.

So why do so many people say "it helped"

Because most of the time it really does help, but the reason may not be the supplement.

Changes that come along with it. A person who starts a supplement usually starts paying attention to sleep, food and routine in the same period too.

Fluctuation. ADHD symptoms change from period to period. Whatever is started in a bad period seems to have worked, once things return toward the average.

The effect of doing something. When you give a method money and effort, it becomes easier to find evidence that it worked. I have seen this in myself many times and I do not see it as something to blame; everyone works this way.

The debate about who it might help

There is still a view defended in this field: that the effect may be more pronounced in people whose essential fatty acid intake is low. For someone who never eats fish, a supplement may mean something different than for someone who eats fish twice a week.

This is a reasonable hypothesis, but for today it is a guess. The Cochrane review does not report a separate result for such a subgroup, and I could not find a verified finding.

The practical meaning is this: if you are thinking of starting a supplement, looking first at what you eat is a sensible first step. Looking at the kitchen before buying a box often changes more.

When reading the label

Even so, if you are going to use it, the place to look on the label should not be the total amount of fish oil; it should be the amount of the omega-3 types inside. EPA and DHA are listed separately, and this distinction often sits in small print.

A capsule that says "1000 mg fish oil" can contain 120 mg of EPA. Between two boxes with a price difference, it is very common for the difference in content to be larger.

There is also the matter of freshness: spoiled fish oil capsules can cause stomach upset and belching. The expiry date and storage conditions are talked about less than the numbers on the label, but in daily life they are noticed more.

Other supplements

Iron and B12. These are not supplements; they are treatment if there is a deficiency. A deficiency can produce fatigue and attention problems and is checked with a blood test: the iron and ferritin values. If there is no deficiency, no benefit of taking a supplement has been shown.

Zinc and magnesium. The evidence is weak and inconsistent.

Cutting sugar. There is no evidence. The details are in the article does sugar cause ADHD.

Elimination diets. A separate topic and a separate debate; I covered it in the article does diet help in ADHD.

A supplement does not mean harmless. Omega-3 can affect blood clotting; if you use blood thinners or are going to have surgery, be sure to tell your doctor. Also, supplements are not regulated as strictly as medicines; content and purity can vary between products.

How to read this article

I want to say one thing clearly here, because the sentence "there is no evidence" is easily read as "nutrition does not matter," and that reading is wrong.

What the Cochrane review says is narrow: omega-3 supplementation does not reduce the core symptoms of ADHD compared with placebo. This does not mean that omega-3 has nothing to do with general health, and it does not mean you should stop a supplement your doctor recommended for another reason.

The only thing it says is this: for ADHD symptoms, you should not expect it to be a treatment. After learning this distinction I got much less tired in supplement debates, because now I ask not about the product itself but about which question it answers.

The real risk

This may be the most important sentence of this article: the real risk of supplements does not come from their being harmful; it comes from their delaying the treatment that works.

The time that passes while a supplement is tried for six months is time that could have been used for diagnosis and treatment. Especially in children, this delay has a cost in school and social life. I wrote the same opportunity-cost argument in the article on neurofeedback, because the mechanism is the same.

Using a supplement and getting an assessment do not exclude each other. Both can happen at the same time.

Nutrition still matters

Not as a cause. As a factor that affects the course. Going hungry directly makes focusing harder; skipping meals and then eating a lot enlarges the evening crash. I wrote about this side in the article nutrition in ADHD.

For my part, where I arrived is this: that box did not change anything in me, but buying the box for a period kept me from doing what actually needed to be done. Now the question I ask when I look at a supplement has changed. Not "could it do harm" but "what am I not doing instead."

Frequently asked questions

Does omega-3 reduce ADHD symptoms?
The 2023 Cochrane review, which evaluated thirty-seven studies, found no improvement in ADHD symptoms compared with placebo and reported this with high certainty.
Why did the older studies look positive?
Early meta-analyses reported a small but significant effect. When more and better-designed studies were added, that effect disappeared.
Then why do so many people say it helped?
The expectation effect, other changes made in the same period and the natural fluctuation of symptoms can produce this impression.
Is taking omega-3 harmful?
The real risk is postponing the actual treatment because the supplement is thought to replace it. A doctor should be consulted before starting a supplement, especially if blood thinners are in use.

supplementsnutritionADHD

How this article was prepared

Cansu is an adult living with ADHD, not a doctor or health professional. This is a compilation rather than a personal account: the information rests on published studies and official sources, listed under the article.

It has not been reviewed by a clinician. Decisions about diagnosis, medication and treatment belong with your doctor, and details about rights, forms and procedures differ by country and change over time, so check them with the relevant authority. More about this site.

Sources5
  1. Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 50(10), 991-1000.
  2. Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018). Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis. Neuropsychopharmacology, 43(3), 534-545.
  3. Gillies, D., Leach, M. J., & Perez Algorta, G. (2023). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews, 4, CD007986.
  4. Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S. et al. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses. American Journal of Psychiatry, 170(3), 275-289.
  5. Cortese, S., Adamo, N., Del Giovane, C. et al. (2018). Comparative efficacy and tolerability of medications for ADHD. The Lancet Psychiatry, 5(9), 727-738.

This page was updated on 16 September 2026.